List view / Grid view

liver disease



NICE recommends liver disease drug

21 March 2017 | By Niamh Marriott, Junior Editor

NICE has published draft guidance which recommends Ocaliva, also known as obeticholic acid, for people with the chronic liver disease...


FDA grants fast track for Shire’s NASH investigational treatment

29 July 2016 | By Mandy Parrett, Editorial Assistant

Shire Plc has announced today that the United States Food and Drug Administration (FDA) has granted Fast Track designation for SHP626 (volixibat) for an investigational treatment of adults with nonalcoholic steatohepatitis (NASH) with liver fibrosis.